Skip to main content

Structured products

Wrap it up and start again

Marketing structured products is a tough challenge, with both nascent and established markets battered by the Lehman Brothers collapse. Meanwhile, providers must also adapt their techniques to suit interactive and online channels, and be increasingly…

More speed, more efficiency

Banks are increasingly aware of the speed and efficiency that is required to process data when creating and dealing in structured products. Calls for transparency and liquidity mean it is vital to choose systems that can cope with the products'…

'X' marks the spot

In a little over two years, DB x-trackers has captured an impressive 17% share of Europe's ETF market. With an existing portfolio of more than 100 products, the provider now plans to expand its offering in Asia while developing new product types such as…

The trace race

The concept of traceability has been a great success in the food industry. Would its adoption by the structured products industry be the quickest way to restore confidence in European markets and help a shattered banking sector? Participants at last…

Preaching protection

Continuing a series of interviews with national regulators about structured products, we talk to Maria Jose Gomez Yubero, head of investor protection at the Comision Nacional del Mercado de Valores, about the fallout from the Lehman Brothers bankruptcy,…

Pricing options on film revenue

This article illustrates two models for cumulative revenues from films, a time-changed gamma process and a compound Poisson process, and how these models can be used to price options. Don Chance, Eric Hillebrand and Jimmy Hilliard find that while both…

Barclays reissues target growth plan

Barclays Wealth has reissued the Target Growth Plan, which is designed to provide exposure to the FTSE 100 index and offers a potential return of 50% at maturity. Barclays aims to raise £5-10 million on the plan.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here